Alpha Tau Medical Ltd. Ordinary Shares (DRTS)

Price$7.97

Favorite Metrics

Price vs S&P 500 (26W)84.98%

Price vs S&P 500 (4W)1.98%

Market Capitalization$693.52M

All Metrics

Book Value / Share (Quarterly)$0.88

P/TBV (Annual)2.01x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.37

Price vs S&P 500 (YTD)56.55%

EPS (TTM)$-0.53

10-Day Avg Trading Volume0.26M

EPS Excl Extra (TTM)$-0.53

EPS (Annual)$-0.53

ROI (Annual)-51.08%

Cash / Share (Quarterly)$0.83

ROA (Last FY)-40.35%

EBITD / Share (TTM)$-0.51

ROE (5Y Avg)-62.89%

Cash Flow / Share (Annual)$-0.37

P/B Ratio9.00x

P/B Ratio (Quarterly)5.47x

Net Income / Employee (Annual)$-0

Net Interest Coverage (TTM)-135.30x

ROA (TTM)-42.39%

EPS Incl Extra (Annual)$-0.53

Current Ratio (Annual)7.45x

Quick Ratio (Quarterly)7.32x

3-Month Avg Trading Volume0.33M

52-Week Price Return205.43%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$1.33

52-Week High$8.60

EPS Excl Extra (Annual)$-0.53

CapEx CAGR (5Y)10.01%

26-Week Price Return88.97%

Quick Ratio (Annual)7.35x

13-Week Price Return11.14%

Total Debt / Equity (Annual)0.08x

Current Ratio (Quarterly)7.45x

Enterprise Value$687.667

Revenue / Employee (Annual)$0

Cash / Share (Annual)$0.83

3-Month Return Std Dev76.62%

Net Income / Employee (TTM)$-0

ROE (Last FY)-55.29%

Net Interest Coverage (Annual)-14.93x

EPS Basic Excl Extra (Annual)$-0.53

Total Debt / Equity (Quarterly)0.08x

EPS Incl Extra (TTM)$-0.53

ROI (TTM)-53.01%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$1.53

Price vs S&P 500 (52W)175.60%

Year-to-Date Return59.19%

5-Day Price Return7.21%

EPS Normalized (Annual)$-0.53

ROA (5Y Avg)-39.41%

Month-to-Date Return11.46%

EBITD / Share (Annual)$-0.54

LT Debt / Equity (Annual)0.08x

ROI (5Y Avg)-60.79%

LT Debt / Equity (Quarterly)0.08x

EPS Basic Excl Extra (TTM)$-0.53

P/TBV (Quarterly)2.29x

P/B Ratio (Annual)5.47x

Book Value / Share (Annual)$0.88

Price vs S&P 500 (13W)10.45%

Beta1.07x

Revenue / Share (TTM)$0.00

ROE (TTM)-57.29%

52-Week Low$2.50

Analyst Recommendations

Jan 2026

Feb 2026

Mar 2026

Apr 2026

4.30

4.20

About

Alpha Tau Medical is a clinical-stage oncology company developing Alpha DaRT, a proprietary technology that harnesses alpha particles for localized radiation therapy to treat solid tumors. The technology leverages alpha particles' therapeutic properties while addressing their traditionally limited range. The company is advancing its clinical pipeline with operations based in Israel.